SUSTIVA (REMEDYREPACK INC.)
Welcome to the PulseAid listing for the SUSTIVA drug offered from REMEDYREPACK INC.. This Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Analog [Chemical/Ingredient],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],Cytochrome P450 2C9 Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | REMEDYREPACK INC. |
| NON-PROPRIETARY NAME: | efavirenz |
| SUBSTANCE NAME: | EFAVIRENZ |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Analog [Chemical/Ingredient],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],Cytochrome P450 2C9 Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2017-05-05 |
| END MARKETING DATE: | 0000-00-00 |
SUSTIVA HUMAN PRESCRIPTION DRUG Details:
| Item Description | SUSTIVA from REMEDYREPACK INC. |
| LABELER NAME: | REMEDYREPACK INC. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 600(mg/1) |
| START MARKETING DATE: | 2017-05-05 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 70518-0482_4f0c1ed0-f0f9-1e61-e054-00144ff88e88 |
| PRODUCT NDC: | 70518-0482 |
| APPLICATION NUMBER: | NDA021360 |
Other EFAVIRENZ Pharmaceutical Manufacturers / Labelers:
